Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application:
Company:

Products on 071403

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS

Approval Date(s) and History, Letters, Labels, Reviews for

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/21/1987	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/16/2008	SUPPL-32	Labeling		Label is not available on this site.
06/15/2005	SUPPL-22	Labeling		Label is not available on this site.
03/31/1993	SUPPL-12	Labeling		Label is not available on this site.
10/14/1988	SUPPL-4	Labeling		Label is not available on this site.

Therapeutic Equivalents for 071403

LORAZEPAM

TABLET;ORAL; 0.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ATIVAN	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	Yes	AB	017794	BAUSCH
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	077396	ANI PHARMS
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	203572	AUROBINDO PHARMA
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	218597	GRAVITI PHARMS
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	078203	LEADING
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	077754	OXFORD PHARMS
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	071141	SANDOZ
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	076045	SUN PHARM INDS LTD
LORAZEPAM	LORAZEPAM	0.5MG	TABLET;ORAL	Prescription	No	AB	072926	WATSON LABS